Investment Summary

Kensington Capital Partners Invests In minus

On March 8, 2022, private equity firm Kensington Capital Partners invested in distribution company minus

Investment Highlights
  • This is Kensington Capital Partners’ 1st transaction in the Distribution sector.
  • This is Kensington Capital Partners’ 18th transaction in Canada.
  • This is Kensington Capital Partners’ 13th transaction in Ontario.

Investment Summary
Date 2022-03-08
Target minus
Sector Distribution
Investor(s) Kensington Capital Partners
Deal Type Growth Capital

Target

minus

Toronto, Ontario, Canada
minus is a distributed food waste solutions company dedicated to investing in the intersection between traditional waste services and distributed technology, to measurably reduce the cost and environmental impact of food waste. The company operates in 14 countries, transforming conventional food waste services through its hyperlocal technology – ORCA. minus was founded in 2018 and is based in Toronto, Ontario.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Kensington Capital Partners

Toronto, Ontario, Canada

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1996
PE ASSETS 2.8B CAD
Size Large
Type Sector Agnostic
DESCRIPTION

Kensington Capital Partners is a Canadian alternative asset manager focused on hedge funds, private equity, and infrastructure assets. Kensington makes private equity investments through its fund-of-funds and direct co-investment programs. Kensington Capital was formed in 1996 and is based in Toronto.

DEAL STATS #
Overall 24 of 25
Sector (Distribution) 1 of 1
Type (Growth Capital) 8 of 8
State (Ontario) 13 of 13
Country (Canada) 18 of 19
Year (2022) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-15 Deep Genomics

Toronto, Ontario, Canada

Deep Genomics has developed a platform that uses deep learning-based technology to help geneticists, chemists, and molecular biologists create drug therapies. Its software system searches across billions of molecules and pinpoints compounds that can be used to alter the composition of cells. Deep Genomics was founded in 2014 and is based in Toronto, Ontario.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-03 Resolute Health

Bedford, Nova Scotia, Canada

Resolute Health is a healthcare services business specializing in the testing and treatment of obstructive sleep apnea (“OSA”). Resolute Health was founded in 2005 and is based in Bedford, Nova Scotia.

Buy -
Mergr

Product

Company

Legal